Physician profile
Christian Prada
NPI 1518994482
$30,008.22
in general payments reported to CMS, 2019-2025
12 companies · $1,217 in 2025
The $1,217 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $616 · 2021: $553 · 2022: $822 · 2023: $692 · 2024: $908 · 2025: $1,217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,818.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,817.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $26,696.42 | 2019-2022 | |
| Abbvie INC. | $2,326.70 | 2023-2025 | |
| Galderma Laboratories, L.P. | $205.50 | 2019-2025 | |
| Motiva USA, LLC | $177.83 | 2025 | |
| Tepha INC | $164.62 | 2019 | |
| Sientra, INC. | $162.36 | 2020-2022 | |
| Revance Therapeutics, INC. | $135.72 | 2024-2025 | Daxxify |
| Davol INC. | $73.93 | 2023 | Phasix Mesh |
| Boston Scientific Corporation | $23.03 | 2023 | Ams 700 Cxr Rte Kit |
| Elite Orthopedics, LLC | $14.54 | 2024 | |
| Covidien LP | $14.39 | 2020 | |
| Mentor Worldwide LLC | $13.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christian Prada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.